No Data
Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?
Earnings Scheduled For January 22, 2025
Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $159
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Johnson & Johnson's Nasal Spray Gets FDA Nod as Depression Treatment
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday